Medicare Enrolled

Dr. Anna Lines, ARNP

Physician Assistant · Orange City, FL
Low-engagement
2555 S VOLUSIA AVE, Orange City, FL 32763
3867740401
In practice since 2017 (8 years)
NPI: 1114433828 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lines from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lines? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lines

Dr. Anna Lines is a physician assistant in Orange City, FL, with 8 years in practice.

Between the years covered by Open Payments, Dr. Lines received a total of $5,915 from 42 pharmaceutical and/or device companies across 311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lines is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice$ $5,915 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,915
Total received (2021-2024)
Avg $1,479/year across 4 years
Top 5% in FL for physician assistant
42
Companies
311
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,915 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,432
2023
$1,620
2022
$2,158
2021
$704

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$735
Novo Nordisk Inc
$666
AstraZeneca Pharmaceuticals LP
$608
Otsuka America Pharmaceutical, Inc.
$474
Lilly USA, LLC
$305
Boehringer Ingelheim Pharmaceuticals, Inc.
$295
SANOFI-AVENTIS U.S. LLC
$249
Astellas Pharma US Inc
$193
Amgen Inc.
$192
Radius Health, Inc.
$188
Phathom Pharmaceuticals, Inc.
$162
AbbVie Inc.
$143
Abbott Laboratories
$140
GlaxoSmithKline, LLC.
$135
Currax Pharmaceuticals LLC
$132
Dexcom, Inc.
$121
Avanir Pharmaceuticals, Inc.
$102
Amarin Pharma Inc.
$97
PFIZER INC.
$92
Novartis Pharmaceuticals Corporation
$92
Ultragenyx Pharmaceutical Inc.
$86
Axsome Therapeutics, Inc.
$79
Exact Sciences Corporation
$76
Janssen Pharmaceuticals, Inc
$66
Sumitomo Pharma America, Inc.
$53
Bayer HealthCare Pharmaceuticals Inc.
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
Bayer Healthcare Pharmaceuticals Inc.
$40
Merck Sharp & Dohme LLC
$33
Takeda Pharmaceuticals U.S.A., Inc.
$33
IDORSIA PHARMACEUTICALS US INC
$29
Harmony Biosciences LLC
$25
Endo Pharmaceuticals Inc.
$24
Sunovion Pharmaceuticals Inc.
$24
Lundbeck LLC
$23
Teva Pharmaceuticals USA, Inc.
$19
Scilex Pharmaceuticals Inc.
$19
SCILEX PHARMACEUTICALS INC.
$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
EISAI INC.
$15
Xeris Pharmaceuticals, Inc.
$15
Eisai Inc.
$13
Top 3 companies account for 34.0% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AIRSUPRA · AJOVY · AVEED · Aduhelm · Auvelity · BELSOMRA · BREZTRI · CAPLYTA · CONTRAVE · CUVITRU · Cologuard Collection Kit · Crysvita · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GVOKE PFS · JARDIANCE · Kerendia · LEQVIO · LINZESS · MOUNJARO · Myrbetriq · NUEDEXTA · Nuedexta · ONZETRA XSAIL · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · QULIPTA · QUVIVIQ · RELISTOR · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STIOLTO RESPIMAT · SYNJARDY · SYNTHROID · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · VYNDAMAX · Vascepa · Veozah · WAKIX · Wegovy · XARELTO · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for physician assistant in FL.

Looking for a physician assistant in Orange City?
Compare physician assistants in the Orange City area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician Assistants within 10 mi
373
Per 100K population
65.6
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lines is a physician assistant, and high industry engagement (low-engagement, top 5%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Lines receive payments from pharmaceutical companies?
Yes. Dr. Lines received a total of $5,915 from 42 companies across 311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Lines) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →